- .
- .
august 29, 2017. - eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention..
why is melania trump still in hospital?..
richard lipton, md, director, montefiore headache center; edwin s. lowe professor and vice chairman of neurology, albert einstein college of medicine..
cambridge's bluebird bio licenses delivery tech to novartis, gsk. http://ndaviesco.com/Burdzel-daughter-of-Nab-from-Asbacherhutte?Brandissi=146 .